Chemical Structure


  • Consulting

    JD consults with all sizes of public and private companies, universities and charities and also CROs.

    These include retained consultancies, ad hoc consultancies and scientific board memberships.

  • Non-exec directorships

    JD is a non executive director of Xenogesis and Sentinel Oncology. He is also director of INMED.

  • Drug Design and Drug Discovery

    JD works with companies at all stages of drug design, drug discovery and early drug development covering:

    - All aspects from target selection via CD nomination to early clinical studies.

    - Advice on strategy and tactics as well as milestone definition and transition reviews.

    - Specific focus on individual projects and advice on portfolio and pipeline issues.

    - Portfolio and pipeline reviews.

  • Licencing and alliances

    JD works with companies on all aspects of:

    - Partner identification, collaboration selection, licencing evaluation, negotiation, participation in inward and outward licencing.

    - Definition and management of Research Collaborations and project and supervisory levels.

    - Due diligence both direct and third party.

  • Outsourcing

    JD advises on selection of suitable CROs as well as definitions of contracts and management of interactions.

    The overwhelming objective is the identification of positive cost benefit solutions.

  • Intellectual Property and Patenting

    Patent strategy definition, patent analysis and due diligence, litigation and expert witnessing.